Angela M. Siesky - Concepedia

Concepedia

Author

Angela M. Siesky

Eli Lilly (United States)

Also Known As

A. M. Siesky, Angela M. Siesky, Angela Siesky

11

Publications

1.9K

Citations

11

H-Index

29

Concepts

All Affiliations

Eli Lilly (United States)Ionis Pharmaceuticals (United States)Indiana University – Purdue University Indianapolis

AM

About

Angela M. Siesky is an author at Eli Lilly (United States) specializing in metabolism, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.4K
2	Health Sciences	4	4	1.4K
3	Biochemistry	3	3	1.3K
4	Diabetes	3	3	1.4K
5	Endocrinology	2	2	1.3K

Angela M. Siesky

×

11

Publications

1.9K

Citations

11

H-Index

	Year	Citations
Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance William L. Holland, Joseph T. Brozinick, Liping Wang, Cell Metabolism ObesityMetabolic SyndromeBiochemistryMedicineInsulin Management	2007	1.2K
Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky, Journal of Clinical Investigation	2004	210
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides Merrill D. Benson, Barbara Kluve‐Beckerman, Steven R. Zeldenrust, Muscle & Nerve	2006	146
Acute‐Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice Ludger Scheja, Barbara Heese, Heike Zitzer, Journal of Diabetes Research Acute‐phase SerumMetabolic DisorderImmunologyPathologyAdipokines	2008	89
Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice Daniel A. Briere, Xiaoping Ruan, Christine C. Cheng, PLoS ONE Metabolic SyndromeBiochemistryGastrointestinal PharmacologyGallbladder FillingDiabetes	2015	74
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo Timothy B. Durham, James L. Toth, Valentine J. Klimkowski, Journal of Biological Chemistry	2015	51
Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α Tonghuan Hu, Patricia Foxworthy, Angela M. Siesky, Endocrinology Exclusive SiteLipid PeroxidationLiver SteatosisFatty Liver DiseaseLiver X Receptor	2005	44
Hepatic Effects of 2-Butoxyethanol in Rodents Angela M. Siesky Toxicological Sciences Hepatic EffectsLipid PeroxidationPathologyPharmacotherapyExperimental Pharmacology	2002	37
Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease Kyle W. Sloop, Aaron D. Showalter, Amy L. Cox, Journal of Biological Chemistry	2007	18
Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky, Journal of Clinical Investigation	2004	14

Page 1